Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMBAT-SAB: Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

NCT07376889 is registered in ClinicalTrials.gov with Intermountain Health Care, Inc. as lead sponsor.

NCT NCT07376889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07376889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMBAT-SAB: Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Lead sponsor
Intermountain Health Care, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2026
Completion date
January 31, 2029
Enrollment
2,096 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia